Author： Bloor K.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.17, Iss.6, 2000-06, pp. : 539-544
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
What's new in disease management?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. :
Access to resources
Recommend
Cholinesterase Inhibitors in Alzheimer's Disease: Are they Worth the Cost?
CNS Drugs, Vol. 11, Iss. 3, 1999-03 ,pp. :
Dopamine agonists cost effective for cotherapy of Parkinson's disease?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 332, 2001-01 ,pp. :
What's the real cost of preventing chronic disease in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Lyme disease vaccine worth its cost in the US?
Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. :